Accessibility Menu
 
Glaukos logo

Glaukos

(NYSE) GKOS

Current Price$135.94
Market Cap$8.21B
Since IPO (2015)+349%
5 Year+49%
1 Year+68%
1 Month+24%

Glaukos Financials at a Glance

Market Cap

$8.21B

Revenue (TTM)

$551.35M

Net Income (TTM)

$189.33M

EPS (TTM)

$-3.29

P/E Ratio

-42.60

Dividend

$0.00

Beta (Volatility)

1.21 (Average)

Price

$135.94

Volume

68,909

Open

$139.37

Previous Close

$135.94

Daily Range

$134.82 - $140.93

52-Week Range

$73.16 - $146.75

GKOS: Motley Fool Moneyball Superscore

71

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Glaukos

Industry

Healthcare Equipment and Supplies

Employees

1,094

CEO

Thomas William Burns

Headquarters

Aliso Viejo, CA 92672, US

GKOS Financials

Key Financial Metrics (TTM)

Gross Margin

78%

Operating Margin

-16%

Net Income Margin

-34%

Return on Equity

-26%

Return on Capital

-11%

Return on Assets

-21%

Earnings Yield

-2.35%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$8.21B

Shares Outstanding

58.53M

Volume

68.91K

Avg. Volume

754.18K

Financials (TTM)

Gross Profit

$393.22M

Operating Income

$86.73M

EBITDA

$44.39M

Operating Cash Flow

$46.34M

Capital Expenditure

$7.67M

Free Cash Flow

$54.01M

Cash & ST Invst.

$278.76M

Total Debt

$139.64M

Glaukos Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$150.57M

+41.2%

Gross Profit

$117.23M

+42.4%

Gross Margin

77.86%

N/A

Market Cap

$8.21B

N/A

Market Cap/Employee

$8.25M

N/A

Employees

995

N/A

Net Income

$19.78M

-9.0%

EBITDA

$6.97M

+38.7%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Net Cash

$173.63M

-10.1%

Accounts Receivable

$119.69M

+67.3%

Inventory

$62.38M

+4.9%

Long Term Debt

$103.06M

-2.3%

Short Term Debt

$0.00

N/A

Return on Assets

-21.19%

N/A

Return on Invested Capital

-10.69%

N/A

Free Cash Flow

$16.48M

+19.4%

Operating Cash Flow

$12.53M

+32.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ACLXArcellx, Inc.
$115.07+0.00%
BLCOBausch + Lomb Corporation
$16.30-0.06%
ARWRArrowhead Pharmaceuticals, Inc.
$76.39+2.11%
ALKSAlkermes plc
$34.17+2.37%

Trending Stocks

Symbol / CompanyPricePrice Chg
CNSPCns Pharmaceuticals
$7.84+2.39%
GBTGGlobal Business Travel Group
$9.34+0.58%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$13.18+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.69-0.00%

Questions About GKOS

What is the current price of Glaukos?

Glaukos is trading at $135.94 per share.

What is the 52-week range for Glaukos?

Over the past 52 weeks, Glaukos has traded between $73.16 and $146.75.

How much debt does Glaukos have?

As of the most recent reporting period, Glaukos reported total debt of $103.06M.

How much cash does Glaukos have on hand?

Glaukos reported $104.25M in cash and cash equivalents in its most recent financial results.

What is Glaukos’s dividend yield?

Glaukos does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.